Stallion India Fluorochemicals Allots 3.67 Crore Rights Issue Shares at Rs. 99 Each

Stallion India Fluorochemicals Limited has successfully completed its rights issue with the Rights Issue Committee approving the allotment of 3,67,60,483 equity shares. The committee meeting, held on March 2, 2026, at the company's registered office in Mumbai, concluded the rights offering process that was initiated earlier this year. Rights Issue Details The rights issue was structured in a 19:41 ratio, meaning eligible shareholders received 19 new equity shares for every 41 existing shares held. The allotment was priced at Rs. 99.00 per equity share, with each new share carrying a face value of Rs. 10.00. Rights Issue Parameters: Details Allotment Quantity: 3,67,60,483 shares Issue Ratio: 19:41 Issue Price: Rs. 99.00 per share Face Value: Rs. 10.00 per share Record Date: February 11, 2026 Letter of Offer Date: February 12, 2026 Updated Share Capital Structure Following the completion of the rights issue allotment, the company's paid-up equity share capital has been restructured. The new capital structure reflects the addition of the rights issue shares to the existing share base. Capital Structure Post-Allotment: Details Total Equity Shares: 11,60,85,737 shares Face Value per Share: Re. 1.00 Total Paid-up Capital: Rs. 1,16,08,57,370 Committee Approvals and Regulatory Compliance The Rights Issue Committee meeting commenced at 6:40 PM and concluded at 7:00 PM on March 2, 2026. The committee's decisions were made in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Key approvals from the committee meeting included: Allotment of 3,67,60,483 fully paid-up equity shares to eligible shareholders Extinguishment of lapsed rights entitlements Deactivation of rights entitlements ISIN INE0RYC20010 Regulatory Framework The allotment process was conducted pursuant to the Letter of Offer dated February 12, 2026, and followed the Basis of Allotment approved by BSE Limited, which served as the Designated Stock Exchange for this rights issue. The company has informed both the National Stock Exchange of India Limited and BSE Limited about the completion of the allotment process as required under regulatory guidelines. Stallion India Fluorochemicals Limited has secured a significant milestone in its expansion strategy with RIICO's approval for land allotment for its proposed Hydrofluoroolefin (HFO) manufacturing plant in Rajasthan. The development strengthens the company's position in the fluorochemicals sector and supports its long-term growth objectives in specialty chemicals manufacturing. The Co-MD has expressed confidence in achieving 30-35% revenue growth over the next three years through strategic initiatives. Land Allotment Details The company received approval for Plot No. SP2-9 measuring approximately 53,369 sq. mtrs at the RIICO Industrial Area, Ukhalliya, District Bhilwara, Rajasthan. This new allocation is strategically positioned adjacent to the company's existing land holdings in the same industrial area. Plot Details: Area (sq. mtrs) Plot No. SP2-9 (New): 53,369 Plot SP3-10 (Existing): 40,524 Plot SP3-11 (Existing): 28,650 Total Holdings: 122,543 Strategic Manufacturing Layout The contiguous location of these three adjoining plots enables Stallion India Fluorochemicals to develop a fully integrated manufacturing layout. According to Managing Director & CEO Mr. Shazad Rustomji, this configuration will facilitate shared infrastructure, utilities, security, administration, and common factory management, creating operational synergies and supporting cost optimization as operations scale. Investment and Timeline The proposed HFO manufacturing facility represents an investment of approximately ₹200 crore with the start of work planned in 2027. This follows the company's R-32 project, which is targeted for commissioning by October 2026. HFOs represent the next phase of low-global-warming-potential refrigerant technologies and will significantly strengthen the company's product portfolio and long-term competitiveness. RIPS-2024 Incentives The Rajasthan project will be eligible for incentives under RIPS-2024, including capex-linked benefits. The incentive structure includes: SGST-linked incentives Capital and performance-linked support Interest subvention Employment-linked benefits These benefits can cumulatively extend up to 100% of the eligible fixed capital investment, subject to approvals and eligibility conditions, significantly enhancing project viability and long-term returns. Growth Outlook Backed by these strategic initiatives, the Co-MD has expressed confidence in achieving the targeted 30–35% revenue CAGR over the next three years. The expansion aligns with India's vision of self-reliance in specialty chemicals and fluorochemicals while building a strong domestic manufacturing base for sustainable long-term value creation. We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better. Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians. As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.